iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
NCT ID: NCT04909203
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2023-06-01
2025-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Technology for Reducing and Preventing Adolescent Suicide
NCT04896593
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
NCT07224165
Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care
NCT05282225
Caring Connections Youth Suicide Prevention Care Coordination Study
NCT07167615
Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff
NCT02981420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators hypothesize that in comparison to the active control condition, iKinnect participants will show significantly better outcomes from baseline to the 4, 8, and 16-week assessment points such that:
1. iKinnect parents will report greater increases in parenting and suicide prevention efficacy.
2. iKinnect youth will report greater decreases in suicidal, NSSI, and delinquent/criminal behaviors.
3. iKinnect youth will report greater increases in coping with imminent distress and use of suicide prevention coping strategies.
4. iKinnect parents and youth will report greater increases in clarity of expectations, parental monitoring, discipline effectiveness, parent consistency, use of rewards, and positive parent-youth relations.
5. iKinnect parents will report greater decreases in youth problem behaviors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iKinnect2.0
Parent-Youth dyads assigned to the iKinnect2.0 condition will be given access to the iKinnect2.0 app that has been developed for this study. Parent and youth will be asked to download the app to their phone during the baseline assessment process and asked to use it as often as they would like throughout the duration of the 16 week trial. The app is designed to be used several times throughout each day.
iKinnect2.0
iKinnect2.0 is a paired mobile phone app for use on both Android and iOS operating systems by youth with conduct disorders and their parents.
Attention-Control Placebo App & Supporting Materials
Parent-Youth dyads assigned to the control condition will be asked to download the free Life360 app to their phone during the baseline assessment process and will also be given access to an online suicide resources brochure. Participants will be asked to use the control-condition app and associated materials as often as they would like throughout the duration of the 16 week trial.
Active Control App
Mobile phone app for use on both Android and iOS operating systems for GPS tracking of other persons.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iKinnect2.0
iKinnect2.0 is a paired mobile phone app for use on both Android and iOS operating systems by youth with conduct disorders and their parents.
Active Control App
Mobile phone app for use on both Android and iOS operating systems for GPS tracking of other persons.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in English
* Owns an Android or iPhone-based smartphone with a data plan and is the primary user of the phone
* Primary caregiver and supervisor of a youth aged 15-21 on probation or receiving post-incarceration reentry services at time of screening
* Age 15-21 years
* Fluent in English
* Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan
* Currently resides in same household as linked parent/legal guardian at least 5 days per week
* Has been arrested at least once and is receiving community-based JJ services related to probation or re-entry
* At significant risk for suicide, as evidenced by one of the following: one or more lifetime suicide attempts; elevated past-month suicidal ideation (\>24 on the SIQ-JR99, or self-injury repetition (\>3 lifetime self-harm episodes, including one in the past 12 weeks before screening)
* Willing to disclose NSSI and suicidal behaviors to parent
To ensure consistency of planned and actual enrollment, particularly of Black youth, researchers will begin to exclude youth of certain races once pre-established recruitment milestones for a specific racial group is achieved.
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Maryland
OTHER
Evidence-Based Practice Institute, Seattle, WA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda Dimeff, PhD
Role: PRINCIPAL_INVESTIGATOR
Evidence-Based Practice Institute
Cindy Schaeffer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland, Baltimore
Baltimore, Maryland, United States
Evidence-Based Practice Institute
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.